Obtain a License for Pharmaceutical Activity in Kazakhstan

What follows covers the fee schedule, names the government office that actually picks up the phone, and lays out the practical sequence a pharmaceutical business moves through, from the very first application to the temperature log an inspector eventually pulls up during a site visit.

Outright paperwork failure rarely kills an application in this market; a subtype mismatch, a permit that no longer reflects what the business actually does, is the more common culprit.

The Legal and Regulatory Foundations Behind Pharmaceutical Activity in Kazakhstan

Start with who actually knocks on the door: the regulator of pharmaceutical activity in Kazakhstan operates under the health ministry, through a dedicated committee handling medical and pharmaceutical oversight, itself organized into territorial departments that manage both the paperwork review and the physical walkthrough. Field staff measure a facility against the Sanitary Rules under Order QR DSM-44, and clearing that specific measurement is what finally lets an application land in the register.

Founders often treat the inspector as the last hurdle before opening day. In practice, the Committee's territorial office is usually the first call worth making, since a failed sanitary walkthrough blocks every later stage.

Three legal texts anchor this office's authority, and each one does a different job rather than repeating the others. The broadest is the 2020 health code, No. 360-VI, which simply draws the outer edge of the field: what pharmaceutical work actually is, and which ministry owns the question in the first place.

The health code alone won't say what happens on inspection day; it defines the sector rather than handing out a checklist.

A narrower statute sits underneath it: No. 202-V, covering permits and notifications across dozens of otherwise unrelated industries. It decides how far any given activity has to travel through formal review before it can legally start, and it's why Kazakhstan's pharmaceutical activity licensing falls into the stricter, license-required bracket rather than the lighter notification track many smaller businesses rely on.

A kiosk selling bandages and vitamins sits under a noticeably lighter regime than a compounding pharmacy next door, and that line runs through this statute rather than the health code above it.

The third and most granular piece belongs to the industry alone: Order QR DSM-149/2020 spells out sector detail that neither of the first two documents bothers with, right down to storage humidity thresholds and minimum staffing ratios per shift. Where the health code sets philosophy and the permits law sets procedure, this order is the one an inspector actually carries into the building.

That third document is also where the health code's scope turns into a trap: drug sales and hands-on clinical care share the same text, so drifting toward treating patients can trigger a second licensing track unnoticed.

None of these three texts can substitute for another, and obtain a license for pharmaceutical activity in Kazakhstan really just means clearing all three at once, since each one locks in a different layer of the same safety floor.

The state never hands over one combined checklist spanning all three documents. Founders who treat the sector order as optional reading tend to discover the gap only once an inspector walks the premises.

A newer layer now sits on top of all this. The shift toward common Eurasian Economic Union rules is entering its final stage, and this permit can no longer be separated from product registration under EAEU standards. Certificates issued before the transition must be brought into line with the supranational norms, adding fresh obligations for anyone importing or distributing across the union.

That EAEU layer oddly trips up established operators more than newcomers: a certificate valid two years ago can quietly drift out of compliance with nothing changing on the Kazakhstan side.

Staying in this market for the long haul now means meeting international GxP standards as a baseline, not an option:

• wholesale suppliers answer to the GDP standard for storage and transport;
• the retail segment runs on GPP norms for service quality;
• good-practice certification is a precondition for participating in state procurement under GOBMP and OSMS.

Separately, rolling out medicine marking in Kazakhstan means wiring internal accounting systems into the IS MPT information system, so every package can be traced from factory to consumer by its own Data Matrix code. Dispensing prescription drugs without proper record-keeping, or breaching the marking rules outright, risks suspension; rules like these exist specifically to flush out shadow turnover and counterfeit goods.

Subtypes of the Pharmaceutical License in Kazakhstan, Explained by Format

A license to handle medicinal products ties tightly to one specific line of work rather than functioning as a blanket approval. Before filing, the entrepreneur has to pin down the object's actual function, since the classification of pharmaceutical activity in Kazakhstan splits the market into distinct segments, each carrying its own area norms, staffing bar, and refrigeration kit. Get the subtype wrong and certain operations become off-limits entirely, wholesale sale under a retail-only permit being the classic trap.

Confusing these subtypes stings financially, since reapplying under the right category eats not just processing time but often the seasonal window a supply contract was built around.

Manufacturing sits apart and demands its own approach to site design. A license for the production of medicinal products in Kazakhstan goes only to companies capable of running under full GMP conditions, opening the door to large-volume output for distribution. A facility planning something narrower, compounding preparations against a doctor's prescription, needs a separate in-house manufacturing permit instead, backed by its own lab and sterility bar.

Nobody underestimates the GMP bar on purpose, yet the cost gap between a full production license and a narrower compounding permit still catches applicants who expected the paperwork to scale gently.

Wholesale work, on the distribution side, serves distributors and logistics operators rather than the general public. A license for the wholesale sale of medicines in Kazakhstan grants the right to supply pharmacy chains and medical organizations, with the warehouse standing as the main object regulators check. Holding that warehouse permit confirms a working GDP system and a site able to hold a stable temperature across large storage areas.

A warehouse built for ordinary dry goods rarely clears GDP on the first inspection; verified temperature stability across the whole storage footprint, not one monitored corner, is usually what sends distributors back to the fit-out stage.

Retail is the format most small and medium operators reach for. A license for a pharmacy in Kazakhstan is the common route, letting a broad range of medicines reach the public directly. Facilities inside hospitals or clinics instead rely on the narrower pharmacy-point format, while kiosks in remote rural areas answer to a lighter infrastructure bar.

• retail sale through a pharmacy or pharmacy point: at least 30 sq m combined for the sales floor and storage zone in a city;
• wholesale sale via a pharmacy warehouse: the international GDP standard is mandatory;
• in-house manufacture inside a pharmacy production unit: requires an aseptic block plus dedicated lab equipment;
• industrial production at a plant or pharmaceutical factory: full compliance with GMP and the relevant industrial regulations.

Founders scaling from a single storefront into a small chain trip on exactly this line: once a second location leans more on supplying other outlets than serving walk-in customers, the paperwork quietly shifts toward distribution, whether or not the filing catches up.

Getting registration of a pharmaceutical license in Kazakhstan right starts with mapping the business model honestly before anything gets filed. Where the plan includes online delivery to consumers, a retail permit of this kind needs a companion notification covering the delivery activity itself, and from that point on any delivery vehicle counts as a storage object for temperature-regime purposes.

Delivery is the piece founders most often forget to file for, since the core retail license already feels like the finish line; filing the notification after vehicles are already on the road draws more scrutiny than filing it upfront.

A returned application most often stems from a missed detail in how the activity subtype got described, rather than anything substantive: a wholesale license won't stand in for a retail one, and the reverse holds equally true. The system tolerates no ambiguity in how a permit reads, so sticking to the established classification is what keeps a business clean with inspectors down the line.

A returned file rarely arrives with a full explanation, just a code pointing at the mismatched subtype, which is why matching the declared activity to the real business before submission saves more time than any fast follow-up after rejection.

Staffing and Site Requirements for Pharmaceutical Facilities in Kazakhstan

Every name on the payroll needs a confirmed pharmaceutical qualification, higher or secondary level, no exceptions. Licensing of pharmaceutical activity in Kazakhstan requires each employee dispensing medicines to hold a valid specialist certificate, renewed on the attestation schedule; a facility with no qualified staff on the books gets refused outright.

Renewal dates are easy to lose track of once a pharmacy runs smoothly, and one lapsed attestation among the dispensing staff is enough to put the whole facility's compliance status in question.

Whoever runs the facility needs documented, specialty-relevant experience: two years for someone with higher education, three years for secondary training. A license for a pharmaceutical business in Kazakhstan gets refused without exactly this kind of documented history backing it up; a head who falls short stalls the organization and racks up losses through pure downtime.

Owners rarely budget for this, but staff turnover quietly ranks among the biggest operational risks here: lose the one person whose diploma and tenure satisfy the qualification bar, and the facility can land out of compliance overnight.

The site itself has to be owned by the applicant, or leased on a multi-year basis. Premises requirements for a pharmacy in Kazakhstan set a floor of 30 square meters for urban operators, with ownership data pulled automatically from the state real estate system during filing; rural kiosks work to a lighter standard.

Landlords sometimes list a unit's floor area differently in the state registry than what a tenant measures on site, and closing that gap before filing beats discovering it mid-review.

• a sales floor where visitors are served and goods are sold;
• a receiving area for unpacking and briefly holding incoming products;
• a separate zone dedicated to the main storage of medicinal products;
• an administrative and welfare space for staff rest and inventory work.

Sanitary norms for pharmacy facilities in Kazakhstan set requirements for shelving, trays, and cabinets able to withstand disinfectant treatment, along with wall and floor surfaces smooth enough for wet cleaning; fall short of that sterility bar and a site simply gets flagged as unfit at inspection.

Standard retail shelving fails this test more often than founders expect, since disinfectant-resistant coating isn't something most fixture suppliers stock by default.

Keeping the microclimate steady is what actually keeps medicines safe. Storage temperature gets tracked with calibrated hygrometers and thermometers in every functional zone; refrigeration units need continuous data logging for anything thermolabile, and those logs are exactly what inspectors pull during permit review.

A single unlogged temperature spike often goes unnoticed until the affected batch is already flagged as compromised, the whole reason continuous logging exists.

Security systems get confirmed through installation and maintenance contracts covering the alarm equipment. Clearing this front means a site needs fire and security alarms, barred or impact-resistant windows at ground level, and solid locking hardware at every entrance; skip any part of that checklist and the launch stalls.

Fit-out budgets on this list tend to run higher than founders expect, since disinfectant-resistant shelving, hygrometer-equipped fridges, and barred windows are rarely already installed and get bought specifically for the inspection.

The Step-by-Step Roadmap for Obtaining a License for Pharmaceutical Activity in Kazakhstan

Filing this permit paperwork has gone fully digital, routed entirely via the "Electronic Licensing" system. How to obtain a pharmaceutical license in Kazakhstan is governed by elicense.kz's own service regulation: paper submissions don't get accepted, a digital signature key (EDS) is mandatory, and every field gets filled in remotely.

The four stages below read like a simple checklist, but the moment that actually decides things falls at stage three, the site visit, where a mismatch between what got declared and what the inspector finds outweighs correctly completed paperwork.

Skip a step anywhere in that sequence, or hand over anything inaccurate, and the procedure for obtaining a pharmaceutical license in Kazakhstan grinds to a halt. A wrong facility address, missing staff diplomas, or incomplete equipment data lead straight to a reasoned refusal. Before filing anything, an internal audit of the paperwork and a genuine readiness check on the site pay for themselves.

Most applicants only discover the value of an internal audit after their first rejection; running it before submission is what actually saves the resubmission cycle.

What Documents Licensing a Pharmaceutical Business in Kazakhstan Actually Requires

Gathering data for the pharmacy market has moved to a fully digital standard, which is exactly what simplifies pharmaceutical regulation in Kazakhstan in practice. The elicense.kz system does the heavy lifting itself, generating the application, while everything submitted runs through automatic verification against state systems.

Automatic verification catches format errors quickly, but it can't judge whether a scanned document is the right one, so a quick manual check before uploading still matters.

The form confirming compliance with qualification requirements sits at the center of the whole filing, capturing sales-floor data, storage premises, and who's on staff; get this part of the file right and there's no need to chase down extra paper certificates afterward.

• an electronic request bearing the organization head's EDS;
• a completed form covering the material, technical base, and staff;
• proof that the licensing fee was settled through the gateway;
• a maintenance contract for the fire and security alarm systems;
• specialist diploma copies, wherever the digital registries come up short.

Diploma copies are the item most often missing at filing time, mostly because applicants assume the eGov database already has the record when older or foreign credentials frequently haven't been digitized.

Where a pharmacist's education record doesn't show up in the eGov database, the applicant attaches scanned originals instead. That workaround lets specialists secure a pharmaceutical activity license in Kazakhstan even after training abroad, once nostrification wraps up; the regulator still cross-checks authenticity through interagency requests.

This nostrification gap trips up more foreign-trained pharmacists than the rest of the paperwork combined, since credential recognition runs on its own timeline, separate from the licensing clock.

Title data on real estate gets pulled from the property register in real time. Where a lease or ownership right hasn't yet made it into the unified register, supporting files have to go up by hand; success at this stage depends on how fully the applicant discloses legitimate possession of the site.

Property records that lag behind an actual sale or lease assignment are more common than expected, and chasing that update before filing beats explaining the gap to a reviewer afterward.

Enterprise security gets confirmed through an active monitoring contract for the alarm systems, checked at any site visit. A complete pharmaceutical business license in Kazakhstan file wraps up with a digital case record kept in the system and available for verification.

A monitoring contract that lapsed months ago but never got renewed on paper is a surprisingly avoidable reason for an otherwise-ready file to stall at the final check.

The Price Tag and the Timeline for Licensing Pharmaceutical Activity in Kazakhstan

The financial side of launching a project ties back to a single calculation index fixed annually by the budget law. That index is the MRP, pegged to 4,325 tenge for 2026, a figure that feeds directly into the cost of a pharmaceutical license in Kazakhstan; the payment amount stays fixed no matter where the entity happens to be registered.

Because the index resets annually, a fee estimate carried over from a prior year's budget planning can quietly drift out of date before anyone gets around to filing.

The fee for a pharmaceutical license in Kazakhstan on first issuance comes to ten calculation indices, which lands at 43,250 tenge in 2026; the money goes to the local budget under classification code 105402, and the receipt lands in the taxpayer's cabinet automatically.

That figure covers only the state duty itself; site preparation, staff certification, and equipment sourcing sit outside this line and usually dwarf it in the final budget.

• a primary issuance: 10 MRP, 43,250 tenge, 15 working days;
• reissuance triggered by an address change or a company name update: 1 MRP, 4,325 tenge, 3 working days;
• a duplicate: 10 MRP, 43,250 tenge, 2 working days;
• an annex to the license: 10 MRP, 43,250 tenge, 15 working days.

The duplicate and reissuance categories move noticeably faster than a primary filing, the detail that trips up operators who assume every touch of the process runs on the same fifteen-day clock.

Where an existing document simply needs updating, reissuance of a pharmaceutical license in Kazakhstan handles precisely that situation, and it costs one monthly calculation index; the usual trigger is a legal-address change with no actual relocation, or a change of company name.

Most reissuance requests trace back to something as mundane as a rebrand or a shifted legal address, rarely anything to do with how the pharmacy operates.

Administrative regulation puts a hard ceiling on the registration clock itself: at most 15 working days pass between the application landing on the portal and a decision coming back, a window that has to cover both the paper review and the territorial department's physical visit.

That fifteen-day ceiling rarely turns out to be the binding constraint; whether someone with keys is available when the inspector shows up tends to matter more.

An inspector still has to walk the site to confirm what got declared, and any delay on the business side stretches the timeframe for obtaining a pharmaceutical license in Kazakhstan further out. Block access to the pharmacy or warehouse and the procedure freezes until the obstacle clears; time it well and sales can start within three weeks of filing.

Sales teams sometimes start marketing a launch date before the site visit is even scheduled, which runs backwards, the countdown only really starts once that visit is behind them.

Investors generally find market-entry costs easy to forecast. The full price tag adds the state payment to whatever it takes to prepare the technical base. The core state fee for arranging a pharmaceutical license in Kazakhstan stays a fixed line, and knowing that figure up front lets an operator budget properly for scaling a chain.

The state duty rarely ends up the deciding line on anyone's budget; fit-out, staffing, and sanitary inspection prep usually cost several times more than the fee itself.

Conclusion

Obtaining a license for pharmaceutical activity in Kazakhstan demands genuine discipline in lining up the material, technical, and staffing base before filing. The state has built a genuinely transparent digital environment, but succeeding inside it still hinges on strict compliance with sanitary rules and qualification standards. Licensing today functions less as a barrier and more as a filter keeping unqualified operators out of the market.

Corporate compliance and attention to detail at the design stage are what guarantee the permit arrives on time, and matching the right activity subtype protects both operations and the business from fines.